{"id":"W2136242714","doi":"10.1200/jco.2005.05.0401","title":"Clinical Efficacy of Lenalidomide in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia: Results of a Phase II Study","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lenalidomide; Neutropenia; Internal medicine; Fludarabine; Chronic lymphocytic leukemia; Refractory (planetary science); Rituximab; Gastroenterology; Adverse effect; Phases of clinical research; Progressive disease; Oncology; Surgery; Clinical trial; Leukemia; Multiple myeloma; Toxicity; Chemotherapy; Lymphoma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01225504,0.0003162267,0.004192993,0.0005054991,0.00004540148,0.000005639384,0.0005402573,0.0008066954,0.00009619612],"category_scores_gemma":[0.02078681,0.0001943784,0.0007085562,0.0007089235,0.001030574,0.0001742188,0.0002319274,0.002076835,0.00000916746],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.0327323,"about_ca_system_score_gemma":0.1395428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001007493,"about_ca_topic_score_gemma":0.0007163755,"domain_scores_codex":[0.9848801,0.001851455,0.01053657,0.0005437866,0.001607955,0.0005800682],"domain_scores_gemma":[0.9785803,0.01273249,0.005975846,0.0008302148,0.001397506,0.0004836444],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6936935,0.07128906,0.1234734,0.0003084982,0.001527538,0.004782386,0.0003631789,0.001134545,0.0001290151,0.00001718336,0.006439058,0.09684259],"study_design_scores_gemma":[0.514143,0.2549353,0.2254763,0.000604596,0.0005839709,0.0001096178,0.000100928,0.0008113025,0.00007255774,0.00001873883,0.003004647,0.0001390718],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968373,0.000282214,0.0000160762,0.00019956,0.0005876893,0.00115655,0.00001379256,0.00001153224,0.0008953069],"genre_scores_gemma":[0.9970623,0.0002418477,0.0009500184,0.0001377796,0.001033265,0.000005836869,0.00001200308,0.00004748362,0.0005094371],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1836462,"threshold_uncertainty_score":0.9874615,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08788936020811099,"score_gpt":0.4740014396404239,"score_spread":0.3861120794323129,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}